A novel de novo ATP2B1 variant causes autosomal dominant intellectual developmental disorder 66 by disrupting calcium homeostasis via impaired membrane trafficking
Experimental Biology and Medicine · 2026
DOI: 10.3389/ebm.2026.10834 ↗Kurz gefasst
Fachartikel in der Zeitschrift Experimental Biology and Medicine, 2026. Verfasst von Huanhuan Zang und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pediatrics, The First Affiliated Hospital of Bengbu Medical University, Bengbu, China. Hauptthemen laut MEDLINE: Calcium, Homeostasis, Intellectual Disability, Plasma Membrane Calcium-Transporting ATPases. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 19 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Heterozygous pathogenic variants in ATP2B1 (encoding PMCA1) cause autosomal dominant intellectual developmental disorder 66 (MRD66; OMIM #619910). To date, only 12 pathogenic de novo ATP2B1 variants have been reported in MRD66. This study aimed to identify the genetic etiology in a Chinese infant with a neurodevelopmental disorder characterized by early-onset seizures and global developmental delay (GDD) and functionally characterize a novel ATP2B1 missense variant. Trio-based whole-exome sequencing revealed a heterozygous de novo ATP2B1 variant (c.2140A>C, p.Thr714Pro) in the proband. The proband presented with infantile spasms, GDD (Gesell Developmental Quotient: 65–74), and severe growth restriction (height/weight <−2 SD). To investigate the variant’s pathogenicity, the wild-type (WT) and mutant ATP2B1 constructs, N-terminally tagged with mScarlet, were transfected into HEK293T cells. Confocal imaging demonstrated profound cytoplasmic mislocalization of the p.Thr714Pro mutant protein, contrasting sharply with the characteristic plasma membrane localization of WT ATP2B1. Measurement of intracellular Ca 2+ levels using Fluo-4 AM showed a significant 2.07-fold increase in basal Ca 2+ levels in cells expressing the mutant compared to WT. This finding expands the spectrum of ATP2B1 variants associated with MRD66 and confirms calcium dyshomeostasis as the core pathomechanism. This case of MRD66 demonstrates a very early onset of seizures, consistent with the recognized phenotypic variability and the critical role of PMCA1 in early neurodevelopment.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Pediatrics, The First Affiliated Hospital of Bengbu Medical University, Bengbu, China.
- Anhui Engineering Research Centre for Neural Regeneration Technology and Medical New Materials, Bengbu Medical University, Bengbu, Anhui, China.
- Department of Rheumatology and Immunology, Bengbu Hospital of Shanghai General Hospital/The Second Affiliated Hospital of Bengbu Medical University, Bengbu, China.
Zitieren
APA
Zang, H., Yang, X., Liu, Y., Ma, C., & Yang, D. (2026). A novel de novo ATP2B1 variant causes autosomal dominant intellectual developmental disorder 66 by disrupting calcium homeostasis via impaired membrane trafficking. Experimental Biology and Medicine. https://doi.org/10.3389/ebm.2026.10834
Vancouver
Zang H, Yang X, Liu Y, Ma C, Yang D. A novel de novo ATP2B1 variant causes autosomal dominant intellectual developmental disorder 66 by disrupting calcium homeostasis via impaired membrane trafficking. Experimental Biology and Medicine. 2026. doi:10.3389/ebm.2026.10834
BibTeX
@article{Zang2026,
author = {Zang, Huanhuan and Yang, Xiaoyun and Liu, Yucai and Ma, Caiyun and Yang, Dawei},
title = {A novel de novo ATP2B1 variant causes autosomal dominant intellectual developmental disorder 66 by disrupting calcium homeostasis via impaired membrane trafficking},
journal = {Experimental Biology and Medicine},
year = {2026},
doi = {10.3389/ebm.2026.10834}
}
EUVIMED